The main goal of this work was to identify the mechanisms responsible for carbapenem resistance in 61 Chilean clinical isolates of Enterobacteriaceae (Enterobacter spp., Serratia marcescens, Morganella morganii, Escherichia coli and Klebsiella pneumoniae) with reduced susceptibility to at least one carbapenem (ertapenem, imipenem or meropenem). All of the isolates were analysed for the presence of carbapenemases, extended spectrum b-lactamases (ESBLs), AmpC enzymes and outer-membrane proteins. None of the isolates exhibited carbapenemase activity nor did they have any of the carbapenemase genes that were screened for. Most of the 61 strains produced at least one ESBL and/or one AmpC enzyme and either lost their porins or had altered porins according to sequence analysis. The distribution of ESBLs and AmpC enzymes was different among the species studied. Resistance in K. pneumoniae and E. coli isolates was associated with ESBLs; in M. morganii isolates, resistance was attributed to overexpression of an AmpC enzyme; and in Enterobacter spp. isolates, resistance was associated with both types of enzymes. In K. pneumoniae isolates, porin integrity was more a determinant of carbapenem resistance than the presence of ESBLs, whereas in isolates of Enterobacter spp., M. morganii and S. marcescens, the presence of an overexpressed AmpC enzyme was associated with higher imipenem and meropenem MIC values. Therefore, carbapenem resistance in Chilean isolates is not due to true carbapenemases but rather to a combination of porin loss/alteration and b-lactamase activity. The fact that carbapenemases were not detected in this study is unique, given that many countries in the region have already reported the presence of these enzymes.
INTRODUCTION
Carbapenem resistance among members of the family Enterobacteriaceae has become a major concern in medicine because these antibiotics are reserved for the treatment of severe infections caused by multi-resistant organisms. Carbapenem resistance is gained through the acquisition of carbapenemases (Nordmann et al., 2009 ). Carbapenemaseproducing Enterobacteriaceae have already been reported in many countries worldwide (Radice et al., 2004; Wei et al., 2007) , often being a cause of mortality due to uncontrolled sepsis (Zarkotou et al., 2011) . Therapeutic options for the treatment of infections caused by these bacteria are limited. Colistin and tigecycline are the most frequently used antimicrobials in these cases. Unfortunately, the clinical use of these antimicrobials has been limited by their pharmacokinetic properties and high toxicity. However, other drugs such as gentamicin, phosphomycin and even certain carbapenems have also been used. Carbapenem resistance can also be achieved in the absence of carbapenemases through the derepression of the inherent AmpC-encoding gene, the acquisition of exogenous plasmid-borne cephalosporinase or extended spectrum b-lactamase (ESBL) genes, or via porin permeability reduction. The presence of ESBLs and AmpC is well documented and is reported to be widespread among Enterobacteriaceae (Perez et al., 2007; Jacoby, 2009) . Several members of the family Enterobacteriaceae, including some Enterobacter spp., M. morganii, S. marcescens and E. coli, harbour a natural chromosomal AmpC enzyme. Species like K. pneumoniae do not harbour a chromosomal AmpC gene, although they can bear a plasmid-borne gene that is closely related to the chromosomal gene (Jacoby, 2009) . Chromosomal AmpC enzymes are usually expressed at a negligible level. However, they can become inducible and expressed at high levels. Overexpression of AmpC enzymes can occur by deregulation of the ampC chromosomal gene. AmpC enzymes need to be hyperproduced and associated with porin alterations to generate carbapenem resistance (Nordmann et al., 2009 ). Acquisition of a transferable plasmid-borne ampC gene can also lead to AmpC overexpression because these genes are usually expressed at high levels (Jacoby, 2009) . Alterations in the OmpC or OmpF families of outer membrane proteins of Enterobacter spp. and the OmpK35 or OmpK36 porins of K. pneumoniae have been reported in carbapenem-resistant clinical isolates (Pagès et al., 2008; Doumith et al., 2009) . These alterations include mutations in specific portions of the protein that render the porin non-functional or gene repression that results in subsequent porin loss. Loss of OmpC and OmpF porins has been reported to be responsible for carbapenem resistance in E. coli and S. marcescens isolates (Oteo et al., 2008; Hutsul & Worobec, 1997) . In the case of some M. morganii isolates, decreased carbapenem susceptibility has been attributed to the loss of the major 37 kDa porin (Mitsuyama et al., 1987) . In the case of some Enterobacter cloacae isolates, efflux pumps and porin changes together may confer ertapenem resistance (Yang et al., 2012) .
In this study we detected the presence of carbapenem resistance among clinical isolates of Enterobacteriaceae collected in our clinical microbiology laboratory. However, the mechanisms responsible for these resistances remain largely unknown. The main goal of this work was to determine the resistance mechanisms responsible for the observed reduced susceptibility to carbapenems.
METHODS

Selection of bacterial isolates and inclusion criteria.
Between January 2006 and May 2011, 61 clinical isolates of Enterobacteriaceae were isolated from several patients from our Hospital in Santiago, as well as from other Healthcare Facilities throughout the country, and over an interval longer than 1 week, in order to make sure that the different isolates corresponded to independent infectious events. The specimens included 26 urine samples, 12 wound samples, six peritoneal fluid samples, four tracheal secretions, three blood cultures, three catheter tips, two biliary secretions, one sputum sample, one throat sample and one gastric content sample. The strains were identified with the VITEK 2 System using a GNI+ card (bioMeriéux). Only isolates with reduced susceptibility to at least one carbapenem (imipenem, ertapenem and/or meropenem) were included in this study. Susceptibility (MIC) to imipenem, ertapenem and meropenem was determined by the agar dilution method according to CLSI guidelines (CLSI, 2010) . We used these CLSI breakpoints because most of our strains were isolated and analysed before the implementation of CLSI 2011 breakpoints.
Phenotypic detection of ESBLs, AmpC enzymes and carbapenemases. All of the strains were analysed for carbapenemase activity through the Hodge Test according to the methodology described by Lee et al. (2001) . The presence of metallo-b-lactamases (class B carbapenemases) was evaluated through the MBL E-test (bioMeriéux) according to the manufacturer's instructions.
In order to simultaneously detect the presence of ESBLs and AmpC enzymes, a phenotypic test based on the antibiotic disk diffusion method, described by Coudron (2005) , was used. This test allows the distinction between derepressed and inducible AmpC enzymes.
PCR detection of b-lactamase genes. All of the strains were analysed for the presence of carbapenemases, ESBL and AmpC genes by PCR. DNA extraction was performed using a QIAamp DNA minikit (Qiagen). The primers used for amplification of ESBL and carbapenemase genes are shown in Table 1 . In order to know if they were of the ESBL type, bla TEM and bla SHV genes were sequenced. PCR detection of ampC genes was performed according to the method described by Pérez-Pérez & Hanson (2002) . Six primer pairs were used to amplify genes encoding each one of the six families of AmpC enzymes: ACC, FOX, CMY/MOX, DHA, LAT/CMY/BIL and ACT/ MIR. The following additional primer pair was used to amplify the chromosomal ampC gene from E. coli: Int-B2 : 59-TTCCTGATGATC-GTTCTGCC-39 and Int-HN: 59-AAAAGCGGAGAAAAGGTCCG-39, giving an amplicon of 1315 bp (Smet et al., 2008) . Strains bearing the different b-lactamase and carbapenemase genes were used as positive controls. PCR products were visualized by electrophoresis in 1.5 % agarose gels stained with ethidium bromide.
Imipenem hydrolysis assay. In order to detect carbapenemase activity, crude extracts of bacterial suspensions were analysed spectrophotometrically for their ability to hydrolyse imipenem according to the protocol described by Woodford et al. (2004) . Protein content in crude extracts was quantified by using Protein Assay Dye Reagent (Bio-Rad) and a calibration curve made with serial dilutions of BSA. Results were expressed in mM imipenem protein mg 21 min 21 .
Determination of efflux pump-mediated carbapenem resistance. Mueller-Hinton agar was supplemented when indicated with 12.5 mM carbonyl cyanide-m-chlorophenylhydrazone (CCCP). The differences between the zone diameters around the imipenem and ertapenem disks (40-320 ng) in the plates with or without CCCP were determined.
Analysis of outer-membrane proteins. SDS-PAGE analyses of the insoluble outer-membrane fraction was performed in 12.5 % polyacrylamide slabs as described previously (Lobos & Mora, 1991) . All of the strains were compared to the profile of the sensitive strain for each species. The control strains of E. aerogenes, K. pneumoniae and E. coli were clinical isolates that were sensitive to all three carbapenems tested. The control strain for S. marcescens was ATCC 8100.
Omp, bla TEM and bla SHV gene sequencing. The ompK35 and ompK36 genes of K. pneumoniae isolates were sequenced as described previously (Doumith et al., 2009 ) using the BigDye Terminator v3.1 Cycle Sequencing kit and a 310 Genetic Analyzer (Applied Biosystems). The sequences obtained were compared with wild-type (WT) ompK35 and ompK36 gene sequences (GenBank Accession nos AJ011501.1 and Z33506.1, respectively) using CLUSTAL W software. bla TEM and bla SHV genes were sequenced in the same conditions and sequences were compared to the GenBank database using the BLAST software. 
RESULTS
Clinical isolates and carbapenem susceptibility assays
Between January 2006 and May 2011, 61 clinical strains of Enterobacteriaceae with reduced susceptibility to imipenem, ertapenem or meropenem were isolated from patients at the Hospital of Pontificia Universidad Cató lica de Chile in Santiago, as well as from other healthcare facilities throughout the country. The isolates belonged to the following species: K. pneumoniae (30 isolates), E. cloacae (10 isolates), E. aerogenes (three isolates), E. asburiae (one isolate), E. coli (eight isolates), M. morganii (seven isolates) and S. marcescens (two isolates) ( Table 2 ). According to the breakpoints indicated in CLSI guidelines (CLSI, 2010), among the 61 strains analysed, 21 % (13/61) were resistant and 24.6 % (15/61) were intermediately resistant to imipenem; and 15 % (9/61) were resistant and 21.3 % (13/61) were intermediately resistant to meropenem. Only six isolates were resistant to all three antibiotics assayed ( Table 2) .
Analysis of the presence of carbapenemases
None of the isolates were positive for the presence of class B carbapenemases according to E-test results. Thirteen out of the 61 isolates (21 %) had a positive Hodge test (Table  2) . However, none of the class A (bla KPC , bla IMI , bla SME and bla GES ) or B (bla IMP , bla VIM and bla NDM-1 ) carbapenemase genes were detected by PCR among the isolates studied.
The presence of carbapenemases was further studied through the imipenem-hydrolysis assay as described earlier. None of the isolates had a significant imipenem hydrolysis capacity (Fig. 1 ). The levels of activity detected were significantly lower than that of the positive control (K. pneumoniae ATCC BAA-1705, bla KPC + strain) as demonstrated by ANOVA analysis (Fig. 1 ).
Contribution of efflux mechanisms to carbapenem resistance
All of the isolates except one exhibited no difference in zone of inhibition diameters on plates with or without the presence of efflux pump inhibitor CCCP. E. cloacae isolate no. 20 presented a significant difference between zone of inhibition diameters with (40 mm) or without (10 mm) the CCCP. In this case, carbapenem resistance appeared to be mediated by an efflux pump that was inhibited by CCCP.
Presence of ESBLs and AmpC enzymes and analysis of outer-membrane proteins (porins)
The presence of ESBLs and AmpC enzymes was determined by using a phenotypic assay and PCR analysis. In the case of AmpC enzymes, AmpC activity must be phenotypically detected in order to account for antimicrobial resistance. The distribution of ESBLs and AmpC varied between the different species tested. Porin profiles were also different among the species tested. Therefore, each species was individually analysed.
K. pneumoniae
Taking into account both phenotypic and PCR analyses, 90 % (27/30) of K. pneumoniae isolates had at least one ESBL-producing capability. In contrast, one K. pneumoniae isolate had an AmpC gene and another had derepressed AmpC activity. Therefore, resistance in K. pneumoniae was associated more with ESBLs than with AmpC (Fig. 2) . According to the SDS-PAGE analysis of porins, we observed that most of the K. pneumoniae isolates (20/30) lost their porins or had undergone an alteration in their electrophoretic migration pattern (Table 2 , Fig. 3a ). Fig. 3(a) shows the porin profile obtained through SDS-PAGE analysis of a representative group of K. pneumoniae isolates, showing two isolates that had lost their porins (isolate nos 45 and 42), four isolates exhibiting an unaltered porin pattern (isolates nos 50, 40, 51 and 49) and one isolate (no. 47) showing a modified porin. We hypothesized that in the 10 isolates that conserved their porins, mutations in the functional domains of the porin could contribute to carbapenem resistance. Sequence analysis of the ompK35 gene of these K. pneumoniae isolates demonstrated that most of them had a frameshift mutation and a stop codon at amino acid position 144 (Table 2) . These mutations produce a truncated protein of only 144 amino acid residues (the WT protein has 359 amino acid residues). Moreover, the lack of the Cterminal phenylalanine residue makes the porin unable to be inserted in the outer membrane (Struyvé et al., 1991) . Therefore, the band observed in the SDS-PAGE analysis corresponds most likely to OmpK36, which will be discussed later. Sequence analysis of the ompK36 gene of those K. pneumoniae isolates that conserved their porins demonstrated the presence of insertions, deletions or substitutions throughout the coding sequence. Isolate no. 47 had an insertion of eight amino acids in its OmpK36 porin and, accordingly, a band of higher molecular mass was observed (Fig. 3a) . Most of the isolates that lost their porins had higher imipenem MIC values (¢1) than those that conserved their porins (¡0.5). Eight of the 10 K. pneumoniae isolates that conserved their porins had low-level resistance to imipenem and meropenem and only two of them had intermediatelevel resistance to both carbapenems. In contrast, isolates bearing two ESBL genes had a mean MIC value similar to that of isolates bearing one or no ESBL gene.
Enterobacter spp.
Taking into account both phenotypic and PCR analyses, 64 % (9/14) of the Enterobacter spp. isolates had at least one ESBL gene ( Table 2 ). All of the Enterobacter spp. isolates had an intrinsic ampC gene ACT/MIR and two E. cloacae isolates had in addition an ampC gene of the DHA type. However, the phenotypic test determined that 64 % (9/14) of the Enterobacter spp. isolates had derepressed AmpC activity, whereas five of them did not show any detectable AmpC enzyme activity. Therefore, in the Enterobacter spp. isolates, resistance was associated with both AmpC and ESBL activity (Fig. 2) . SDS-PAGE analysis of E. aerogenes isolates showed that all three of them lost their porins by comparison to the sensitive strain ( Table 2 , Fig.  3b ). These isolates had no ESBL-producing capability but exhibited AmpC overexpression and had high and intermediate levels of resistance to imipenem. Porins from the E. cloacae isolates could not be clearly resolved through SDS-PAGE analysis.
E. coli
Considering both phenotypic and PCR analyses, 88 % (7/8) of the E. coli isolates had at least one ESBL gene ( Table 2) . All of the E. coli isolates had the natural chromosomal ampC gene. However, none of them had derepressed or detectable inducible AmpC activity. Therefore, like in K. pneumoniae, resistance in E. coli is more closely associated with ESBLs than with AmpC (Fig. 2) . According to the SDS-PAGE analysis of porins, we observed that six out of the eight E. coli isolates lost their porins or had an alteration in their electrophoretic migration pattern (Table  2 , Fig. 3c ). Fig. 3(c) shows two E. coli isolates that lost their Fig. 1 . Carbapenemase activity of the isolates analysed. Activity was determined as the imipenem hydrolysis capacity expressed in mM of imipenem hydrolysed mg "1 protein min "1 . The KPCproducing K. pneumoniae strain ATCC BAA-1705 was used as a positive control and E. coli ATCC 25922 (sensitive to all b-lactams) was used as a negative control. Two or three activity determinations were made for each isolate, and isolates of the same species were grouped for easier graphic representation. Bars represent SEM (ANOVA analysis, *** P,0.0005). ns, Not significant. Fig. 2 . Percentage of isolates harbouring AmpC (white bars) and ESBLs (black bars) for the different species. For ESBL distribution, both phenotypic and PCR analysis determinations were considered. Because AmpC enzymes need to be overproduced to generate resistance, only phenotypic determinations were taken into account for AmpC distribution in this graph.
A. Wozniak and others porins (nos 14 and 2) and one isolate (no. 23) that had conserved porins compared to the sensitive strain. In this species group, imipenem MIC values, despite being low, were higher than those for K. pneumoniae, even in those strains that conserved their porins (isolates 23 and 32).
M. morganii
In this bacterium, both phenotypic and PCR analyses showed that 71 % (5/7) of the isolates had at least one ESBL gene ( Table 2 ). All of the M. morganii isolates had an intrinsic DHA enzyme whose activity was detectable as derepressed in four isolates and inducible in three isolates in the phenotypic assay. Resistance in this species group appeared to be associated with both the overexpression of an AmpC enzyme and ESBLs (Fig. 2) . Imipenem MIC values in this species group were indicative of intermediate-level resistance.
Unfortunately, M. morganii isolates showed many different porin patterns, compared to the sensitive isolate, which made the analysis too complex. The different Omp patterns observed are in accordance with the literature revised (Senior & Vörös, 1990) .
S. marcescens
Both S. marcescens isolates had a DHA-type AmpC enzyme that was detected as derepressed in phenotypic analysis. Both isolates exhibited an altered porin pattern compared with that of the control strain ATCC 8100 (Table 2 , Fig.  3d ). Isolate no. 41 expressed a lower amount of OmpF, whereas isolate no. 28 had an altered porin (Fig. 3d ).
Imipenem MIC values were low and intermediate but were higher than the MIC values for K. pneumoniae isolates.
DISCUSSION
To our knowledge, this is the first report of the mechanisms responsible for carbapenem resistance in clinical isolates of Enterobacteriaceae in Chile. Our results demonstrate that carbapenem resistance in the Enterobacteriaceae isolates analysed was not mediated by true carbapenemases. Furthermore, resistance was not mediated by an efflux pump in the large majority of the isolates. Instead, resistance was mediated by porin loss or by mutation of the porin-coding sequence plus an ESBL or AmpC enzyme. Porin loss decreases membrane permeability and therefore antibiotic entry is impaired. Besides this, in the absence of true carbapenemases, ESBLs and AmpC enzymes have a residual capacity to hydrolyse carbapenems, albeit at a very low efficiency. This explains the carbapenemase-free resistance to carbapenems of these isolates. In addition, the 21 % of Hodge-test-positive isolates were indeed false-positives, because all of them were non-carbapenemase producers. This is similar to the 25 % of isolates, in which false-positives were due to CTX-M and AmpC hyperproduction (Pasteran et al., 2009) . However, this is not the case in the present study because the Hodge test-positive isolates were not necessarily CTX-M or AmpC producers. Therefore, for routine carbapenemase screening we now use the Hodge test together with other tests such as the phenylboronic acid test.
Mutations in K. pneumoniae ompK35 and ompK36 genes were different. Most of the ompK35 mutations involved a stop codon that produced a truncated porin, which, we believe, is unable to be inserted into the membrane because the C-terminal phenylalanine residue of OmpK35 is important for membrane anchoring (Struyvé et al., 1991) . In contrast, mutations in the OmpK36 porin involved mostly insertions, deletions or substitutions that did not affect the amino acids that are important for its function (Dutzler et al., 1999) and, thus, the protein would remain functional. This could be due to the fact that OmpK36 is the preferred porin and is conserved by bacteria because it has a smaller pore than OmpK35 and is, therefore, more restrictive of antibiotic entrance (Hernández-Allés et al., 1999) . In fact, Doménech-Sánchez et al. (2003) demonstrated that the carbapenem susceptibility of K. pneumoniae isolates expressing only OmpK35 is four to eight times higher than the same strain expressing only OmpK36. Therefore, the band observed in the polyacrylamide gel in the present study ( Fig.   Fig. 3 . SDS-PAGE analysis of outer-membrane proteins of K. pneumoniae (a), E. aerogenes (b), E. coli (c) and S. marcescens isolates (d). Outer-membrane proteins were extracted and quantified as described and loaded into a 12.5 % polyacrylamide gel. M, molecular mass marker; sens, sensitive strain used as control for each species. The number of each isolate is shown above each lane.
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3) most likely corresponds to the OmpK36 porin in these isolates (isolates nos 40, 49, 51, 52, 44, 48 and 52) .
Because the plasmid-borne ACT/MIR and DHA AmpCencoding genes are closely related to the chromosomal AmpC genes of E. cloacae and M. morganii, respectively, the primers used to amplify these two families of genes also interact with the chromosomal DNA of these two species; hence, their presence in the E. cloacae and M. morganii isolates, which is most likely due to the amplification of the chromosomal AmpC gene, rather than plasmid-borne genes. Four of seven M. morganii isolates had a derepressed enzyme, meaning that mutations could have occurred in the AmpC system, which rendered the gene constitutively expressed. The same could have occurred to the nine Enterobacter spp. isolates that had a derepressed ACT/MIR enzyme. The other five Enterobacter spp. isolates had no derepressed enzyme activity; however, two of them also had a DHA gene, most likely of plasmid origin. All of the E. coli isolates harboured the natural chromosomal AmpC enzyme and none of them exhibited derepressed enzyme activity. Therefore, their carbapenem resistance must be due to CTX-M. The DHA enzyme detected in both S. marcescens isolates was most likely of chromosomal origin and mutations rendered them derepressed. Taking into account all the Enterobacter spp., M. morganii and S. marcescens isolates, it was observed that the presence of a derepressed or inducible AmpC enzyme was associated with higher imipenem and meropenem MIC values. The results obtained with K. pneumoniae isolates highlight the importance of porin integrity in carbapenem resistance and suggest that porin integrity is more important for carbapenem resistance than the presence of ESBLs in this species.
All of the isolates studied exhibited porin loss or porin structure alteration and all of them had at least one ESBL and/or AmpC enzyme except for three K. pneumoniae isolates, one Enterobacter spp. isolate and one E. coli isolate, which did not have an ESBL or an AmpC enzyme. However, three of these isolates had a high-level resistance to imipenem or meropenem. These isolates could have another kind of alteration that could be responsible for carbapenem resistance, for example, expression of a molecule that acts as a blocker of the porin channel and hinders antibiotic entrance into the cell (Pagès et al., 2008) . Another possibility is PBP alteration, i.e. low-affinity PBPs, a resistance mechanism that has been reported in several species, including E. coli (Spratt, 1977) and Pseudomonas aeruginosa (Godfrey et al., 1981) . OXA-48 production could also explain carbapenem resistance in these isolates, in particular when it is expressed together with ESBLs and permeability alterations (Nordmann et al., 2011) .
The fact that we did not detect carbapenemases in these isolates from Chile is remarkable because many countries in this region, like Argentina (Radice et al., 2004) , Colombia (Villegas et al., 2006) and Brazil (Peirano et al., 2009) , have already reported the presence of isolates producing these enzymes. The geographical isolation of Chile may be responsible for this trait, and this concept is further supported by the low frequency of community-acquired meticillin-resistant Staphylococcus aureus in Chile, which is also very frequent in other South American countries, such as Argentina (Tokumoto et al., 2007) , Uruguay (Benoit et al., 2008) and Brazil (Ribeiro et al., 2005) . There are other countries in which class A carbapenemases, i.e. KPC enzymes, have not yet been detected, according to a recent report from the European Society of Clinical Microbiology and Infectious Diseases. These are countries whose geographical isolation is quite evident, for example, Australia and Japan. There are other regions of the world in which KPCs have not been described yet, such as Africa, East Europe and Central Asia. It is possible that they could already exist in most of these countries but have not been detected yet. Further studies will search for the presence of carbapenemases in asymptomatic carriers in order to broaden the spectrum of patients that could be bearing carbapenemase-producing Enterobacteriaceae (Gutiérrez, personal commucication).
